BioCision introduces cryopreservation products to support stem cell research programs

Published on December 10, 2012 at 11:17 AM · No Comments

As part of its ongoing effort to support the scientific community, BioCision LLC, a leader in the advanced temperature management of biomedical samples, announced the availability of free "Cool Stem Kits" to academic stem cell research programs in the U.S. and Europe. Stem cells are a promising area of research for an array of treatments and cures, but cultures require frequent handling and many labs lack the equipment needed to ensure the reproducibility required for clinical research.

“When we discovered BioCision's cryopreservation products, we were eager to incorporate them into our research protocol to further standardize our research methods. The new system has not only increased overall efficiency, it has improved cell viability post thaw.”

"Nearly everyone inside and outside of the scientific community agrees that stem cell research represents one of the most exciting and promising frontiers for treating a myriad of diseases and conditions," said Rolf Ehrhardt, CEO, BioCision. "As an innovator of sample handing, cooling and freezing products, we felt a program like this would be of great service to the stem cell community."

Each "Cool Stem Kit" includes recently launched, second generation cooling products:

  • CoolBox XT Cell Freezing Workstation for ice-free, power-free sample cooling while preparing stem cells for cryopreservation or assays
  • CoolCell® LX Freezing Containers for alcohol-free cell cryopreservation to provide highly reproducible controlled-rate freezing
  • CoolSink XT module to eliminate temperature variability in the incubator or at 4° C
  • TruCool leak proof and barcoded cryovials
  • TruCool ergonomic microcentrifuge tubes
  • CryoCeps cryovials grippers

"The area of stem cell research is full of unknowns, which is part of what motivates scientists," said Rick I. Cohen, Ph.D., Director of the Stem Cell Training Course at Rutgers University. "When we discovered BioCision's cryopreservation products, we were eager to incorporate them into our research protocol to further standardize our research methods. The new system has not only increased overall efficiency, it has improved cell viability post thaw."

 

Source:

BioCision

Posted in: Device / Technology News | Medical Science News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes